Gabelli Funds LLC Personalis, Inc. Transaction History

Gabelli Funds LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.89 - $5.32 $54,537 - $100,393	-18,871 Reduced 20.72%	72,200 $214,000
Q1 2022 May 13, 2022	SELL	$7.56 - $14.3 $37,800 - $71,500	-5,000 Reduced 5.2%	91,071 $746,000
Q4 2021 Feb 11, 2022	SELL	$12.24 - $21.25 $367,200 - $637,500	-30,000 Reduced 23.8%	96,071 $1.37 Million
Q2 2021 Aug 13, 2021	BUY	$18.15 - $27.75 $163,350 - $249,750	9,000 Added 7.69%	126,071 $3.19 Million
Q1 2021 May 14, 2021	BUY	$20.71 - $51.02 $229,280 - $564,842	11,071 Added 10.44%	117,071 $2.88 Million
Q4 2020 Feb 05, 2021	SELL	$21.84 - $44.0 $1.16 Million - $2.33 Million	-53,000 Reduced 33.33%	106,000 $3.88 Million
Q3 2020 Nov 06, 2020	SELL	$13.63 - $24.12 $1.2 Million - $2.12 Million	-88,000 Reduced 35.63%	159,000 $3.45 Million
Q2 2020 Aug 13, 2020	SELL	$7.65 - $14.11 $459,000 - $846,600	-60,000 Reduced 19.54%	247,000 $3.2 Million
Q1 2020 May 14, 2020	BUY	$4.75 - $12.41 $579,500 - $1.51 Million	122,000 Added 65.95%	307,000 $2.48 Million
Q4 2019 Feb 14, 2020	BUY	$8.73 - $12.95 $647,329 - $960,242	74,150 Added 66.89%	185,000 $2.02 Million
Q3 2019 Nov 01, 2019	BUY	$14.16 - $25.34 $1.57 Million - $2.81 Million	110,850 New	110,850 $1.63 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.